Healthcare -
Biotechnology - NASDAQ - US
$ 1.4
7.28 %
$ 73.8 M
Market Cap
-0.47
P/E
ALXO - STOCK-BASED COMPENSATION
Stock-based Compensation ALXO - ALX Oncology Holdings Inc.
26.3 M
LAST VALUE
37.41%
2 YEAR CAGR
150.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR